291 related articles for article (PubMed ID: 20233910)
1. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.
Chang B; Knowles SR; Weber E
Ann Pharmacother; 2010 Apr; 44(4):740-5. PubMed ID: 20233910
[TBL] [Abstract][Full Text] [Related]
2. Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity.
González I; Lobera T; Blasco A; del Pozo MD
J Investig Allergol Clin Immunol; 2005; 15(2):146-9. PubMed ID: 16047716
[TBL] [Abstract][Full Text] [Related]
3. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Iannini PB
Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
[TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
Kovacic D; Fox M; Reichenberg J
J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
[TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin and torsade de pointes.
Dale KM; Lertsburapa K; Kluger J; White CM
Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
[TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis.
Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC
Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304
[TBL] [Abstract][Full Text] [Related]
7. Systemic anaphylaxis caused by moxifloxacin.
Sánchez-Morillas L; Rojas Pérez-Ezquerra P; Reaño-Martos M; Laguna-Martínez JJ; Gómez-Tembleque P
Allergol Immunopathol (Madr); 2010; 38(4):226-7. PubMed ID: 20089346
[No Abstract] [Full Text] [Related]
8. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
[TBL] [Abstract][Full Text] [Related]
9. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
[TBL] [Abstract][Full Text] [Related]
10. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Schmid DA; Depta JP; Pichler WJ
Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
[TBL] [Abstract][Full Text] [Related]
11. Allergy to quinolones: low cross-reactivity to levofloxacin.
Lobera T; Audícana MT; Alarcón E; Longo N; Navarro B; Muñoz D
J Investig Allergol Clin Immunol; 2010; 20(7):607-11. PubMed ID: 21314003
[TBL] [Abstract][Full Text] [Related]
12. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
Jones SC; Budnitz DS; Sorbello A; Mehta H
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1099-106. PubMed ID: 23963962
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic testing in suspected fluoroquinolone hypersensitivity.
Seitz CS; Bröcker EB; Trautmann A
Clin Exp Allergy; 2009 Nov; 39(11):1738-45. PubMed ID: 19735271
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
15. Anaphylactoid reaction to ciprofloxacin.
Ho DY; Song JC; Wang CC
Ann Pharmacother; 2003; 37(7-8):1018-23. PubMed ID: 12841811
[TBL] [Abstract][Full Text] [Related]
16. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with moxifloxacin in patients with respiratory tract infections.
Faich GA; Morganroth J; Whitehouse AB; Brar JS; Arcuri P; Kowalsky SF; Haverstock DC; Celesk RA; Church DA
Ann Pharmacother; 2004 May; 38(5):749-54. PubMed ID: 15026565
[TBL] [Abstract][Full Text] [Related]
18. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
Lammintausta K; Kortekangas-Savolainen O
Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
[TBL] [Abstract][Full Text] [Related]
19. A statement on cefazolin immediate hypersensitivity: data from a large database, and focus on the cross-reactivities.
Pipet A; Veyrac G; Wessel F; Jolliet P; Magnan A; Demoly P; Bousquet PJ
Clin Exp Allergy; 2011 Nov; 41(11):1602-8. PubMed ID: 22093010
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of moxifloxacin in patients with antibiotic hypersensitivity.
Bozkurt B; Karakaya G; Kalyoncu AF
Allergol Immunopathol (Madr); 2005; 33(1):38-41. PubMed ID: 15777522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
